Gilead Sciences acquires German biotech company for $1.39 billion By: San Francisco Business Times via Business Journals December 10, 2020 at 11:25 AM EST The acquisition aims to boost Gilead’s development and commercialization of therapeutics for treating the chronic hepatitis delta virus. Read More >>